Hypertension Scientific Sessions 2022

2022 年高血压科学会议

• 批准号: 10539105
• 负责人: ALEXANDER STARUSCHENKO
• 金额: $ 4万
• 依托单位: UNIVERSITY OF SOUTH FLORIDA
• 依托单位国家: 美国
• 财政年份: 2022
• 资助国家: 美国
• 起止时间: 2022-08-01 至 2023-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10539105
• 关键词: Adult; Advocacy; American Heart Association; Area; Award; COVID-19 pandemic; California; Cardiovascular Diseases; Cardiovascular system; Caregivers; Case Study; Cessation of life; Clinical; Clinical Sciences; Data; Development; Discipline; Education; Event; Expenditure; Faculty; Feedback; Functional disorder; Funding; Genetic; Goals; Grant; Heart Diseases; Hypertension; Institution; International; Journals; Kidney; Kidney Diseases; Manuscripts; Mission; Morbidity - disease rate; National Heart, Lung, and Blood Institute; Nature; Obesity; Oral; Patients; Peer Review; Persons; Physiology; Postdoctoral Fellow; Primary Health Care; Publications; Publishing; Request for Proposals; Research; Research Personnel; Running; Science; Scientist; Seasons; Senior Scientist; Stroke; Students; Time; Travel; Underrepresented Populations; United States; Woman; Work; authority; base; care providers; career; clinical practice; design; early-career faculty; graduate student; interest; knowledge base; lectures; meetings; obesity genetics; oral communication; peer; posters; symposium; virtual

Project Summary Nearly half of adults in the United States (47%, or 116 million) have high blood pressure (hypertension). If untreated, hypertension can cause heart disease and stroke. The purpose of this application is to request travel funds to support trainees who wish to attend and participate in the Hypertension Scientific Sessions 2022 to be held on September 7–10, 2022 in San Diego, California. Hypertension Scientific Sessions are organized by two Councils of the American Heart Association: Council on Hypertension and Council on Kidney in Cardiovascular Disease. This meeting is considered one of the most important and prestigious meetings focused on hypertension. The conference includes oral and poster presentations selected from abstracts submitted by clinical and basic researchers, followed by discussions run by leading authorities. Attendees will have the opportunity to interact closely with experts from around the world involved in cross-disciplinary research in hypertension, cardiac and kidney disease, genetics, stroke, and obesity. This meeting will offer sessions specifically designed to benefit trainees and early career investigators. In addition, Clinical Practice topics focused on applying clinical science to the clinician’s practice and Primary Care programming dedicated to practical advice for the Primary Care Provider treating patients with hypertension will be offered. After two years of virtual conferences due to the COVID-19 pandemic, hypertension researchers are eager to re-engage in face- to-face dialogue, networking, and scientific discussion. By supporting the travel, education, and development of these promising early-career scientists, we hope to expand and diversify the current workforce, ultimately increasing research in the scope of hypertension research. The specific aims of 2022 Hypertension Scientific Sessions and this application are: 1) Provide early-career attendees with a forum to present their research and obtain constructive feedback from a knowledgeable international audience of scientists working in the field of hypertension; 2) Encourage trainees to enhance their current knowledge base by attending state-of-the-art and cutting-edge symposia and lectureships organized by the Hypertension Sessions Planning Committee; 3) Offer trainees an opportunity to network with their peers and senior scientists in the area of hypertension; and 4) To increase the diversity of underrepresented groups in science amongst speakers and moderators. This award will facilitate URM researchers, trainees, and early career researchers at a time when institutions are still limiting expenditures on travel.

项目摘要 在美国，近一半的成年人（47％或1.16亿）具有高血压（高血压）。如果 未经治疗的高血压会导致心脏病和中风。本申请的目的是要求旅行 支持希望参加和参加高血压科学会议2022的学员的资金 2022年9月7日至10日在加利福尼亚州圣地亚哥举行。高血压科学会议由两个组织组织 美国心脏协会的理事会：心血管中肾脏高血压和肾脏理事会理事会 疾病。这次会议被认为是最重要，最负面的会议之一 高血压。会议包括从提交的摘要和海报演示的 临床和基础研究人员，然后由领先当局进行讨论。与会者将有 与参与跨学科研究的全球专家紧密互动的机会 高血压，心脏和肾脏疾病，遗传学，中风和肥胖症。这次会议将举行会议 专门设计的旨在使学员和早期职业调查人员受益。此外，临床实践主题 专注于将临床科学应用于临床实践和专门用于的初级保健计划 将提供针对治疗高血压患者的初级保健提供者的实用建议。两年后 在由于19日大流行而引起的虚拟会议中，高血压研究人员渴望重新参与面部 - 面对面的对话，网络和科学讨论。通过支持旅行，教育和发展 这些承诺的早期科学家，我们希望扩大和多样化当前的员工队伍，最终 增加了高血压研究范围的研究。 2022年高血压科学的具体目的 会议和此申请是：1）为早期的参与者提供一个论坛，以介绍他们的研究和 从知识渊博的国际科学家那里获得建设性的反馈 高血压; 2）鼓励学员通过参加最先进和 高血压会议计划委员会组织的尖端研讨会和讲座； 3）要约 学员有机会与高血压领域的同龄人和高级科学家建立联系；和4）到 在演讲者和主持人中增加科学中代表性不足的群体的多样性。这个奖项 在机构仍在限制的时候，将促进URM的研究人员，学员和早期的职业研究人员 旅行支出。